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Abstract
Introduction
The ability to conduct community-level asthma surveil-
lance is increasingly crucial for public health programming
and child health advocacy. We explored the potential and
limitations of health care use records from both public and
private sources for asthma surveillance in a California
county.
Methods
We combined administrative patient record data from
Kaiser Permanente of Northern California and Medi-Cal
(the California Medicaid program) for Alameda County
residents during 2001. We assessed the resulting data set
for completeness, population representation, consistency
with external data, and internal indicator consistency.
Results
Our resulting data set included records for 226,383 chil-
dren younger than 18 years. Completeness of Medicaid
data was affected by managed care market share, reducing
our usable data set size to 176,789, approximately equal to
one of every two children in the county or one of every 3 per-
son-months. External data documenting hospitalization
rates due to asthma were poorly correlated with hospital-
ization rates (r = 0.2120, P = .20) but highly correlated with
emergency department visits (r = 0.8607, P <.001) in the
resulting data set. High internal consistency of indicators
suggested that the data set represented a broad spectrum
of health care access and quality of care congruent with
clinical aspects of the disease.
Conclusion
The utility of these data is affected by logistical and
administrative factors, including the health care payment
structure and the market shares of care providers. These
factors can be expected to similarly affect the utility of this
approach in other counties. Our ability to generate county-
level health statistics for comparison with other locations
was limited, although the data set appeared well suited for
within-county geographic analysis. In light of these find-
ings, these data have the potential to expand the local
health surveillance capacity of communities.
Introduction
Although asthma has emerged as a major public health
challenge (1), our current needs for asthma surveillance
have far outpaced our capabilities. This problem comes as
no surprise because there is no single test or entirely objec-
tive definition for either the disease or its resolution (2-4).
Historically, surveys of patients and their parents have
been the backbone of asthma surveillance. Cultural differ-
ences and inconsistencies in reporting (5-8), however, as
well as the high cost of survey studies (2,9) make such
methods problematic for ongoing monitoring. At the
national level, asthma surveillance takes the form of a
patchwork of surveys that report symptoms, diagnoses,
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emergency department and clinic visits, and hospitaliza-
tions (1,10). A few states have also taken steps toward
asthma surveillance (11-13). During the past several
years, a consistent picture has emerged of generally rising
morbidity and stark social disparities of the disease, but
the causes of both the spread and the disparities remain
controversial.
Increasingly, childhood asthma prevention and manage-
ment have become a state and local issue as state health
care expenditures have increased and communities have
focused on the impacts of the disease on school districts,
local economic development, and questions of environmen-
tal justice (14-17). Communities seek local asthma surveil-
lance data to enable them to assess small-area variations
in the burden of disease, identify subpopulations at risk,
and plan health resource allocation; however, such data
are generally scarce (18,19). As asthma is increasingly rec-
ognized as being tied to issues of neighborhood segrega-
tion, local air quality, and distribution of health resources,
the demand for local surveillance of the disease can be
expected to increase.
As part of the California Environmental Public Health
Tracking Program (CEHTP), funded by the Centers for
Disease Control and Prevention (CDC), we collaborated
with a private health care provider, Kaiser Permanente of
Northern California; Medi-Cal, California’s Medicaid pro-
gram; and an array of community-based and nongovern-
mental organizations to develop asthma surveillance that
would meet the needs of stakeholders in Alameda County,
a mostly urban county in the metropolitan San Francisco
Bay area. We were interested in our ability to generate
high-quality data that 1) represented the county popula-
tion, 2) provided a complete picture of the geography of
asthma using various asthma-related health events, and 3)
included patient home addresses to enable high-resolution
geographic analysis.
The use of health care services claims for monitoring
asthma morbidity, health care access, and management
has been emphasized as an important next step (20,21),
although few (13,22-24) have described in detail the pos-
sibilities, pitfalls, and limitations of such work. In this
article, we describe our process of evaluating the utility
of health care use data for asthma surveillance and dis-
cuss the logistical and administrative factors affecting
data utility. Technical and statistical procedures for data
analysis, visualization, and surveillance findings are
described in a companion article (25) in this issue of
Preventing Chronic Disease.
Health care use records for asthma surveillance
Analysis of hospitalization rates to reflect the impact of
asthma in populations is a long-standing practice (26),
although it has several limitations. Among children, only
those with asthma that is severe, poorly controlled, or both
are hospitalized, which means that hospitalization rates
are confounded by differences in access to care among pop-
ulations (10,27,28). Furthermore, hospitalization is a com-
paratively rare event relative to overall disease prevalence,
so small-area rates are usually difficult to calculate with
any precision. Some epidemiologists have used 3-year
averages to gain statistical stability at the postal ZIP-code
level, but this seems to be the limit of geographic resolu-
tion for hospitalization data (29). Oyana et al (30) were
able to analyze geographic clustering of asthma hospital-
izations around the Peace Bridge complex in Buffalo, NY,
by aggregating 5 years of such data.
Several investigators have explored the use of health
care billing records for asthma surveillance, an approach
that offers several advantages. Interest has centered on
the possibility that health care events other than hospital-
ization, such as emergency department visits, outpatient
visits, and symptom and maintenance medication pur-
chases, may be available for surveillance purposes, which
could greatly expand the pool of people identified as having
asthma. In populations with good access to care, mortality,
hospitalizations, and emergency department visits would
not be expected to be elevated even with a relatively high
prevalence of asthma (31) (Figure 1). Similarly, among
populations with poor access to care, these indicators
would be expected to be elevated out of proportion to the
asthma prevalence. Our hope is that assessing the rates of
lower acuity or routine events will lead to a more complete
picture of asthma in geographically defined populations.
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Figure 1. The spectrum of health care use indicators for asthma by quality
of care.Some efforts have been made to evaluate the usefulness
of billing records for asthma surveillance in Canada (32). A
few studies have also used insurance claims data for the
study of occupational disease (33-35). A group of investiga-
tors in Milwaukee (23) sought out records from area hospi-
tals, clinics, and health maintenance organizations
(HMOs) to estimate asthma burden. They were able to
monitor both emergency department and outpatient visits
(in addition to hospitalizations) for asthma in a relatively
low-cost, potentially sustainable manner.
Other researchers have attempted to use medication
purchasing patterns to construct indices of asthma in pop-
ulations. This approach is consistent with U.S. national
guidelines, which explicitly include medication use when
classifying asthma severity (31). A Canadian group was
able to roughly classify patients according to the severity of
their asthma using medication records (24), although it
cautions that such an approach in the United States would
be confounded by differences in health care access among
populations. A North Carolina group examined health care
use, including medication purchasing, among Medicaid
beneficiaries and was successful in quantifying prevalence
by age, race, and rural or urban residence (36). A consen-
sus is emerging that medication purchasing information is
an important component of records-based asthma surveil-
lance that requires development (10,26).
All of these studies have cited the need for comprehen-
sive indicators of asthma impact beyond hospitalization
rates as a motivation for investigating the use of health
care billing records. Curiously, none mentions an addition-
al advantage related to the use of such records — the avail-
ability of patient address data to enable surveillance of
asthma in small geographic areas. Advances in geograph-
ic coding, spatial statistics, and geographic information
mapping have made possible the calculation and presenta-
tion of disease rates at sub-ZIP-code resolution while pre-
serving patient confidentiality (37).
Evaluating health care use records for surveillance 
purposes
We evaluated the utility of health care use records from
public and private sources for monitoring asthma among
children. We were particularly interested in the feasibili-
ty of using these data to meet the surveillance needs of
local stakeholders, which included quantifying and visu-
alizing health disparities, identifying populations at ele-
vated risk for asthma, and informing discussions of envi-
ronmental justice by linking them to broader population
health issues.
To evaluate this feasibility, we constructed a working
data set for Alameda County, a diverse, urban county in
Northern California of 1.4 million residents. We examined
1) data completeness, 2) resulting population representa-
tion, 3) external consistency of the data with the previ-
ously understood distribution of asthma in Alameda
County, and 4) internal consistency of the indicators with
each other.
Methods
Data sources
Health care use data were drawn from two sources. The
first was Kaiser Permanente of Northern California
(KPNC), an integrated health care delivery system that is
the region’s largest single provider of health services. Out
of the total 3.1 million members of KPNC, 577,687 were
residents of Alameda County during 2001; approximately
40% of county residents received their care at KPNC dur-
ing that year. Kaiser Permanente maintains a complete
list of enrollees (denominator data) and databases describ-
ing hospitalizations, clinic visits, referrals, external claims,
and medication purchases by members (numerator data)
and uses these for both administrative and health care
services research purposes. (For examples, see Davis et al
[38] and Schoen et al [39].)
The second source was Medi-Cal, which covered 227,086
beneficiaries in Alameda County during 2001. Medi-Cal is
a complicated data source because the state has subcon-
tracted patient care through HMOs since 2001. As of 2001
in Alameda County, all patients qualifying for zero share-
of-cost Medicaid benefits were required to enroll in one of
the two managed care plans in the county, Blue Cross of
California or Alameda Alliance for Health. (Other benefici-
aries are given the option to join.) We investigated the
reporting rates of health care use by the HMOs to the state
Department of Health Services in Sacramento by compar-
ing them to use rates under the fee-for-service arrange-
ment. Finally, a small portion of Kaiser Permanente
enrollees (1.7% of the total, 3.2% of children) are also Medi-
Cal patients subcontracted through the Alameda Alliance
for Health (Figure 2).
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We compared these data to hospitalization counts
abstracted by the California Office of Statewide Healthcare
Planning and Development (OSHPD). Hospitals are
required by law to report these data to OSHPD; the data
represent 100% of hospitalizations in the state. Although
hospitalizations are the only asthma-related event recorded
by OSHPD, and the patient’s ZIP code of residence is the
sole geographic field available, these data are the near-
est thing to a gold standard to which we can compare
numbers generated from the Kaiser Permanente and
Medi-Cal data sets.
Defining asthma events
Hospitalizations, emergency department visits, and out-
patient visits in the data sets included fields for primary
and, in certain cases, secondary diagnoses. For compar-
isons with existing data sets, such events were considered
asthma-related if the primary diagnosis began with the
digits  493, the International Classification of Diseases,
Ninth Revision, Clinical Modification (ICD-9-CM) code for
asthma. For health surveillance, however, we also includ-
ed events with asthma as the secondary diagnosis and a
primary diagnosis of pneumonia,  respiratory failure, or
another condition for which an asthma exacerbation was
likely to be the cause.
We classified medications as asthma related based on
their functional class and divided them into symptom (or
rescue) and maintenance (or  controller) medications.
Symptom medications included long- and short-acting beta
agonists and anticholinergics; maintenance medications
included antileukotrienes, mast cell stabilizers, methylx-
anthines, and inhaled corticosteroids. (The corticosteroids
could be present alone or in combination with bronchodi-
lating agents). Oral corticosteroids were omitted because of
concern that their use for reasons other than asthma was
commonplace enough to compromise the specificity of the
indicator. The classification of long-acting beta agonists as
symptom rather than maintenance medications was sub-
ject to extensive debate. In the end, the lack of evidence
(40) for long-term efficacy of these drugs, particularly in
preventing hospitalizations, argued against their classifi-
cation in the maintenance category. It was later noted that
this classification algorithm is identical to that construct-
ed independently by Buescher and Jones-Vessey (36).
Patient addresses
Home addresses were obtained from records directly
maintained by KPNC and Medi-Cal. These were standard-
ized using ZP4 (Semaphore Corp, Pismo Beach, Calif); they
were subsequently geocoded using a custom application
written in Java 2 Platform, Standard Edition (Sun
Microsystems Inc, Santa Clara, Calif) and ArcSDE version
9.0 (ESRI, Redlands, Calif). Geocoded address coordinates
were taken from the first successful match of the following
four street centerline data sets (in order): Dynamap/2000
version 13 (Tele Atlas, Lebanon, NH), Navstreets (Navteq,
Chicago, Ill), Tele Atlas MultiNet (Tele Atlas, Lebanon,
NH), and the Census 2000 TIGER/Line (U.S. Census
Bureau, Washington, DC). For each street centerline data
set, the first attempt to match an address was made by
indexing the address’s ZIP code. Failing that, the soundex
phonetic code of the address’s city was matched against an
index of the soundex phonetic code of the street centerline’s
post office name, based on its ZIP code. We have noted the
spatial accuracy of assignment to census tracts by this
method to be approximately 99%.
Statistical analysis
To measure data completeness, we used a straightfor-
ward frequency analysis. For assessment of population
representation, we used frequency analysis preceded by
the coding of each patient to the census tract of residence,
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Figure 2. Administrative sources for health care billing records in Alameda
County, California. Shaded circles indicate enrollee populations able to be
included in the analysis because of completeness of records. Approximately
3.9% of Kaiser Permanente person-months represent Medi-Cal beneficiaries
subcontracted through Alameda Alliance for Health.roughly following the methods of Krieger (41). To deter-
mine the consistency of indicators with external data
sources and among each other, we applied bivariate corre-
lation analysis to data aggregated to the ZIP-code and cen-
sus-tract levels, respectively. For the ZIP-code level, we
calculated the Pearson correlation coefficients between the
OSHPD ZIP-code level hospitalization rates and the
Kaiser Permanente hospitalization rates, the Medi-Cal
fee-for-service rates, both combined, and the emergency
department visit rates from both combined. For all analy-
ses, we used SAS version 8.02 (SAS Institute, Cary, NC).
Results
The Medi-Cal fee-for-service and KPNC data combined
to represent 226,383 children younger than 18 years, or 2.3
million person-months of information. Usable sample size
was subsequently reduced in light of data quality consid-
erations.
Data completeness
The hospitalization rate calculated for Medi-Cal fee-for-
service seems to be consistent with the rate calculated
using the OSHPD data (Figure 3). Both managed care sub-
contractors in the county, however, reported hospitaliza-
tions at a substantially lower rate than either of these
sources. Managed care rates of emergency department vis-
its, outpatient visits, and medication purchases also con-
sistently amounted to a small fraction of those calculated
using Medi-Cal. For this reason, subsequent analyses
excluded the managed care Medi-Cal population, reducing
the total sample size to 176,789 children, or 1,656,266 per-
son-months.
Population representation
Comparison with fee-for-service beneficiaries
revealed that managed care enrollees were more likely
to be younger than 18 years (61% compared with 21%),
and among children, they were more likely to be
enrolled in Medi-Cal for the entire 12 months of the
year (55% compared with 19%). For Kaiser
Permanente data, we coded enrollees to their census
tract of residence. In this manner, we could estimate
the proportion of the sample in each income stratum
and compare these figures to those for the overall pop-
ulation using 2000 U.S. census data. The enrollee 
population shows high congruence with the overall
socioeconomic profile of the county, although it slight-
ly underrepresents populations on either extreme of
the continuum and overrepresents those in the middle
(Figure 4).
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Figure 3. Hospitalization rates attributable to asthma (primary diagnosis
only) among Medi-Cal beneficiaries during 2001 in Alameda County,
California, by source of data. The Office of Statewide Healthcare Planning
and Development (OSHPD) includes 100% of county residents receiving
Medi-Cal benefits; the other three data sources include only their respective
portions of this population. The OSHPD rate is calculated for children aged
0 to 14 years; all other rates are for children aged 0 to 17 years.
Figure 4. Population representation of Kaiser Permanente of Northern
California enrollee population, Alameda County, California, 2001.VOLUME 3: NO. 3
JULY 2006
Consistency with external data
We assessed the validity of our data by comparing
them with the OSHPD data set, from which hospitaliza-
tion rates due to asthma were available by ZIP code
aggregated from 1998 to 2000. Neither data set individ-
ually nor combined produced a picture of the geographic
distribution of asthma hospitalizations consistent with
the external data set (Table 1). Among the county’s
health care providers, Kaiser Permanente hospitaliza-
tion rates tend to be low (approximately 50% of the coun-
tywide rate in 2001); this reduction seems to apply
throughout the county, because the variance across ZIP
codes is much lower for KPNC enrollees (78.33) than it is
for the population as a whole (1499.33). Given the large
number of KPNC enrollees in the data set, the low cor-
relation of hospitalization rates is likely to be because of
this decrease in variance.
Rates of emergency department visits for the two data
sets, however, were much more highly correlated with
OSHPD asthma hospitalizations, and this correlation
was higher for both of the data sets combined (r = 0.8607,
P < .001) than it was for either one alone. Thus, ZIP
codes with high OSHPD asthma hospitalization rates
also tended to have high emergency department visit
rates as contained in our data sets, which is consistent
with the notion that people in these areas may have
more severe asthma, poorly controlled asthma, or both.
Internal consistency
We posited that the quality-of-care profile of each cen-
sus tract within the county would fall along a spectrum
of access and quality of care similar to that shown in
Figure 1. Pearson correlation coefficients between the
health care use indicators at the census tract level are
shown in Table 2. The indicators closest to each other on
the spectrum of care (such as hospitalizations and emer-
gency department visits) in Figure 1 are indeed the most
highly correlated, whereas those farther apart (such as
hospitalizations and maintenance medication purchas-
es) are progressively less correlated with each other.
After removal of incomplete records, the data set
described a total of 311,774 asthma-related health care
events among 1,656,266 person-months, not including
hospitalizations. The numbers of each event type are
shown in Table 3.
Discussion
In this study, we evaluated the use of routinely collect-
ed health care use data that could be used for an ongoing
asthma surveillance system in California. By focusing on
administrative health care use data from private and
public sources, we were able to make available a range of
asthma indicators much broader than our previous hos-
pitalization data alone. The use of these databases also
provides an additional advantage for surveillance
because patient data are available at the home-address
level. We assessed the quality of the assembled data for
completeness, population representation, consistency
with external sources describing the distribution of asth-
ma morbidity in the county, and internal consistency of
the indicators with each other.
Data completeness
We knew at the outset that data completeness would be
most open to questions concerning the state (Medicaid)
data, and analysis showed that the key determinant of
completeness was the extent to which the beneficiary pop-
ulation was enrolled through managed care rather than
fee-for-service systems. For Alameda County in 2001, fee-
for-service enrollees had complete data through the state
office in Sacramento, whereas managed care enrollees did
not. This finding has important implications for the devel-
opment of asthma surveillance systems using Medicaid
data, because 48 of the 53 U.S. states and territories with
Medicaid programs use capitated managed care plans,
with enrollment ranging from less than 10% to up to 100%
of the Medicaid population (42). The total proportion of
Medicaid enrollees served through managed care plans
increased from 40% in 1996 to more than 60% in 2003 (42),
and although some states have a uniform set of managed
care options for all enrollees statewide, some (including
California) vary by county (42). Under these arrange-
ments, routine reporting of health care events and central-
ization by the state program is more likely to be incomplete
or absent than under traditional fee-for-service systems.
Population representation
Medicaid data provide a picture of health care use for the
county’s lowest-income residents; our interest in working
with Kaiser Permanente data, in contrast, stemmed from
the possibility of representing health care use by people
from various socioeconomic strata. Consistent with the
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Permanente data performed this role well, although they
slightly underrepresented individuals at either extreme of
the spectrum and slightly overrepresented those in the
middle. It is unclear to what extent the underrepresenta-
tion of these extremes may affect asthma surveillance; it is
hoped that the inclusion of Medi-Cal enrollees may offset
the underrepresentation of low-income communities. As
with our findings on the completeness of Medicaid man-
aged care data, these findings should be expected to vary
by county in California because multiple managed care
entities control varying portions of the state health care
market by region.
Our ability to assess the degree to which the fee-for-serv-
ice portion of the Medi-Cal population was representative
of the entire Medi-Cal population was limited. Racial and
ethnic data recorded by Medi-Cal, when collected, are con-
sidered unreliable, although we could discern that man-
aged care beneficiaries were more likely to be children, and
among children they were more likely to be longer-term
beneficiaries. The process by which Medi-Cal beneficiaries
are assigned to managed care or fee-for-service plans is
complex, with choice of assignment contingent upon the
administrative mechanism of eligibility. This finding sug-
gests that episodic enrollment is more common among fee-
for-service beneficiaries and that enrollment in managed
care plans increases with the duration of eligibility.
Overall, the nonrandom nature of the study sample is
a limitation; it precludes the calculation of countywide
asthma-related health care use rates for comparison to
state or national figures. On the other hand, one of every
two child residents of the county is included in the data
set, or one in three if the figure is calculated using per-
son-months. Because of this fact and the finding that the
data set had high external validity, we felt that the data
set was useful for within-county sociodemographic and
geographic comparisons.
External validity
Our ability to mirror the geographic patterns known
from the OSHPD gold standard data set using the health
care event data sets could not be taken for granted. On one
hand, we had a private managed care data set with high
overall population representation but with a population for
whom hospitalization rates (but not emergency depart-
ment visits) were known to be lower than the countywide
average. On the other hand, we had a public payer data set
restricted to the communities with the lowest incomes in
the county   communities also known to experience a dis-
proportionate share of hospitalizations due to asthma. It
was not clear whether one of these data sets, or both data
sets combined, would most accurately reflect the overall
geographic distribution of asthma events.
Neither the patient records for Medi-Cal, Kaiser
Permanente, nor both combined generated a geographic
pattern of hospitalization rates particularly consistent
with the OSHPD data. We believe this failure to be attrib-
utable to the low hospitalization rates across the county for
KPNC enrollees, which compresses the variance of this
variable. Rates of emergency department visits, by con-
trast, correlated highly with OSHPD hospitalizations, par-
ticularly for the combined data set. Part of the advantage
of the combined data set may originate from superior rep-
resentation across ZIP codes of socioeconomic strata since
KPNC underrepresents families with very low incomes,
who are disproportionately represented among individuals
hospitalized for asthma. Medi-Cal, by contrast, overrepre-
sents those with low incomes but has beneficiaries in fewer
ZIP codes around the county. The combined data set may
capitalize on the strengths of each. Finally, among children
aged 0 to 14 years, the age distribution of the combined
data set more closely matches the general population than
either one alone (data not shown).
Emergency department visits were highly correlated
with hospitalization rates from OSHPD data even though
hospitalization rates and emergency department visit
rates, being separate phenomena, might not be expected to
match each other precisely. Because both hospitalizations
and emergency department visits can be expected to reflect
the distribution of severe, poorly controlled asthma in the
county, however, it is logical that the geographic variations
of each should correlate somewhat. Furthermore, Kaiser
Permanente, as a centrally coordinated managed care
organization, is able to steer patients away from hospital
admissions by encouraging extensive emergency depart-
ment management before making decisions to admit or
discharge patients and implementing case management
strategies in the interests of both cost savings and quality
of care. Because our hospitalization rates are numerically
driven by the Kaiser Permanente patients, it makes sense
that our hospitalization rates, but not our emergency
department visit rates, would be depressed in both magni-
tude and variance relative to the countywide numbers
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from OSHPD. Therefore, for analytical purposes (25), we
focused on emergency department visits as our indicator of
severe asthma, poorly controlled asthma, or both and
excluded hospitalizations.
Countywide, rates of other asthma-related health care
use were largely consistent with national data. Emergency
department visit rates based on the National Ambulatory
Medical Care Survey (NAMCS) (1) for this age group are
very close to the rates found in this study population.
Medication purchasing rates reported from the Medical
Expenditure Panel Survey (43) are also consistent with
this population, although the Alameda County population
seems to purchase a greater proportion of maintenance
medications than would be expected from the national
numbers. Outpatient visit rates were also substantially
higher in the Alameda County population than would be
expected based on the national NAMCS numbers (1).
Considering the large numbers of KPNC enrollees in the
data set, both of these differences may be because of asth-
ma management strategies promoting primary and pre-
ventive care within that organization.
Internal validity
The high degree of internal consistency of the health
care use indicators noted in this data set reinforced our
view of these indicators as representing various posi-
tions on a spectrum of asthma quality of care (Figure 1).
Events that would be expected to occur together (such as
hospitalizations with emergency department visits or
symptom medication purchases with maintenance med-
ication purchases) indeed did so, and events associated
with different standards of asthma primary care (such as
hospitalizations and maintenance medication purchas-
ing) did not. The ability to reflect this spectrum of qual-
ity of care was a major objective for developing these
data sets because of stakeholder interest in comprehen-
sively representing the problem of asthma in the county.
Other measures of data utility
Other authors have also discussed attributes for the
assessment of data sources for health surveillance pur-
poses (44). These include quantitative attributes such as
sensitivity (completeness), representativeness, validity,
and timeliness, as well as qualitative attributes such as
simplicity, acceptability, and cost. We directly assessed
all of the qualitative attributes in this study except for
timeliness. Medi-Cal patient encounter data have taken
an average of 4 months for processing before becoming cen-
trally available through the Medical Care Statistics
Section of the California Department of Health Services,
although the speed of this process appears to be increasing.
One problem with receiving data is the time needed to
screen it for quality assurance purposes. Sacrifices in data
quality may be necessary to increase the value of the data
for surveillance with the understanding that surveillance
data results are preliminary. Similarly, it is the experience
of KPNC’s Division of Research that a lead time of approx-
imately 6 months is required before complete patient
encounter data are available. This provider is currently
developing a comprehensive electronic medical record sys-
tem, however, which is expected to make data available
almost in real-time.
External factors affecting data quality
The potential to adapt the data sources for surveillance,
particularly outside of the demonstration area of Alameda
County, is affected by several issues. A primary require-
ment for this approach to be adopted elsewhere would be
the ability to incorporate private sources of data that rep-
resent a large market share of health services coverage in
that location. Similarly, the proportion of Medi-Cal data
that is fee-for-service or managed care varies by county. We
expect that these two issues will play the greatest role in
determining the extent to which similar systems could be
implemented in other localities in the state or nationally.
Automated geocoding and address verification systems
that were developed for this project could be used in
other counties to make the analytic process more effi-
cient. Similarly, the adoption of data standards by all
managed care entities would be of great value for sur-
veillance. With collaborations among private local
providers of health care use data, data costs could be
minimal. However, there are additional costs for data
processing, data visualization and analysis, hardware,
software, personnel, and data dissemination.
Finally, in contrast to concerns expressed by many col-
leagues, the provisions of the Health Insurance Portability
and Accountability Act of 1996 (HIPAA) did not constitute
an obstacle for the conduct of this work. The fundamen-
tally research-oriented objectives of the project partly
explain this lack of difficulty, as did the absence of intent
to contact any of the patients described in the database.
8 Centers for Disease Control and Prevention • www.cdc.gov/pcd/issues/2006/jul/05_0186.htm
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only
and does not imply endorsement by any of the groups named above.Safeguards for the protection of confidential information
were prepared in advance, and the use of density estima-
tion mapping for the visualization of the data (25) was seen
as a further protection of confidentiality. Full authoriza-
tion from the state Department of Health Services
Committee for the Protection of Human Subjects was
sought and obtained before the project began.
We constructed this working data set to increase asth-
ma surveillance capacity to facilitate clinical and public
health interventions. For two reasons, the result repre-
sents a substantial step forward. The first is the fact that
we were able to incorporate a range of asthma-related
indicator variables into a single data set with ample sta-
tistical power (Table 3), meeting a need expressed by
several researchers (10,24,26). Furthermore, because of
the availability of patient address data, we enable high-
resolution geographic analysis of asthma in the county,
as demonstrated in our companion article (25). Through
this activity, we are able to identify subpopulations fac-
ing increased vulnerability to asthma and barriers to
care, quantify socioeconomic disparities in patterns of
asthma care, and formulate hypotheses about local
sources of pollution or other environmental contributors
to the impact of disease.
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Tables
Table 1. Correlations of Asthma Hospitalization and
Emergency Department (ED) Visit Rates for Children Aged 0
to 14 Years From 2001 Surveillance Data Sets With
Countywide Childhood Asthma Hospitalizations,a Alameda
County, California
Hospitalizations
Kaiser Permanente only 31 0.2625 .15
Medi-Cal fee-for-service only 14 –0.2763 .34
Both 38 0.2120 .20
ED visits
Kaiser Permanente only 36 0.7649 <.001
Medi-Cal fee-for-service only 17 0.2784 .28
Both 38 0.8607 <.001
aOffice of Statewide Healthcare Planning and Development 100% hospital-
ization data set, children aged 0 to 14 years, 1998 to 2000.
bTo minimize the influence of unstable rates on correlation coefficients, only
postal ZIP codes with four or more ED visits were included in calculations.
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No. of 
Health Care Event ZIP Codesb r P ValueVOLUME 3: NO. 3
JULY 2006
Table 2. Internal Consistency of Asthma-related Health Care Use Indicators
ED indicates emergency department; NA, not applicable.
Table 3. Asthma-related Health Care Events Available for Health Surveillance From Combined Data Set (n = 176,789 Children
Aged 0 to 17 Years, or 1,656,266 Person-Months)
Hospitalizations 0a
Emergency department visits 3,579
Outpatient visits 53,611
Purchases of symptom medications 160,029
Purchases of maintenance medications 94,555
aNot used because of poor external validity.
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Health Care Event
Hospitalizations
ED visits
Outpatient visits
Symptom medica-
tion purchases
Maintenance med-
ication purchases
Hospitalizations
r
P
No. of Census
Tracts
1.0000
NA
262
—
—
—
—
ED Visits
r
P
No. of Census
Tracts
0.5980
<.001
262
1.0000
NA
302
—
—
—
Outpatient Visits
r
P
No. of Census
Tracts
0.2331
<.001
232
0.4072
<.001
302
1.0000
NA
321
—
—
Symptom
Medication
Purchases
r
P
No. of Census
Tracts
0.0893
.15
262
0.2213
<.001
302
0.5197
<.001
302
1.0000
NA
321
—
Maintenance
Medication
Purchases
r
P
No. of Census
Tracts
0.0049
.94
262
–0.0266
.64
302
0.4061
<.001
321
0.7448
<.001
321
1.0000
NA
321
Health Care Event Total